US Drug Recall Register
Class I · High risk Terminated Initiated Jan 5, 2022 (5 years ago)

Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Missing Label: label missing from some Semglee prefilled pens.

What was recalled

Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.

Recalling firm
Mylan Pharmaceuticals Inc
NDC code
49502-0196-71
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0462-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Insulin recalls

See all